Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / August 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hersha Hospitality Trust (NYSE:HT)'...
2023-08-21 13:08:17 ET Gainers: Timber Pharmaceuticals ( TMBR ) +97% . China SXT Pharmaceuticals ( SXTC ) +92% . Novo Integrated Sciences ( NVOS ) +43% . Orchestra BioMed Holdings ( OBIO ) +27% . AlloVir ( ALVR ) +26% . The G...
2023-08-21 12:10:02 ET More on Timber Pharmaceuticals Timber Pharmaceuticals to be acquired by Denmark-based LEO Pharma Timber Pharmaceuticals receives NYSE notice on non-compliance Timber Pharmaceuticals stock jumps as much as 83% after FDA waiver to forgo rodent st...
2023-08-21 11:49:06 ET More on Timber Pharmaceuticals Timber Pharmaceuticals receives NYSE notice on non-compliance Timber Pharmaceuticals stock jumps as much as 83% after FDA waiver to forgo rodent study Hot Stocks: AAPL rises to all time high; TGT falls on downgrade;...
Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value Rights Total Transaction Value of up to $36 million Transaction Expected to Close in the 4th Quarter of 2023, subject to closing conditions and stockholder ap...
2023-07-05 12:27:16 ET Biopharmaceutical company Timber Pharmaceuticals ( NYSE: TMBR ) said on Monday that it had received NYSE American notice on non-compliance with the stock exchange's rules related to losses. The company had reported losses from continuing operations and/o...
WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orph...
- First presentation of data from Phase 3 ASCEND study will feature pharmacokinetic results that indicate minimal systemic absorption of isotretinoin - - Data to be presented at the Society for Pediatric Dermatology’s Annual Meeting - WARREN, NJ - ( NewMediaWire ) ...
- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for Pediatric Dermatology’s Annual Meeting - WARREN, NJ, June 20, 2023 (GLOBE NEWSWIRE...
2023-06-06 08:19:00 ET HTG Molecular Diagnostics ( HTGM ) -40% . Ucommune International ( UK ) -16% . EZGO Technologies EZGO -8% on $8.5M direct offering . Timber Pharmaceuticals ( TMBR ) -10% . Celestica CLS -8% on pricing secondary sto...
News, Short Squeeze, Breakout and More Instantly...
Timber Pharmaceuticals Inc. Company Name:
TMBR Stock Symbol:
NYSE Market:
Timber Pharmaceuticals Inc. Website:
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that...
WARREN, NJ - ( NewMediaWire ) - November 28, 2023 - Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated debtors and debtor-...
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated d...